Fleury S.A. (BVMF:FLRY3)
Brazil flag Brazil · Delayed Price · Currency is BRL
14.05
+0.08 (0.57%)
Aug 14, 2025, 4:45 PM GMT-3

Fleury Company Description

Fleury S.A., together with its subsidiaries, provides diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil.

It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides health management services, such as telemedicine; orthopedic medicine services; laboratory support; toxicological exam; preventive, integrated solutions, and clinical research in oncology; integrated solutions, research, development of processes and services in genomics; and laboratory analysis services.

In addition, it operates a health platform, immunobiological drug infusion center, and ophthalmology service centers.

Fleury S.A. was founded in 1926 and is headquartered in São Paulo, Brazil.

Fleury S.A.
Fleury logo
Country Brazil
Founded 1926
Industry Diagnostics & Research
Sector Healthcare
Employees 27,500
CEO Jeane Tsutsui

Contact Details

Address:
Avenida Morumbi
São Paulo, 04703-003
Brazil
Phone 55 11 5014 7236
Website ri.fleury.com.br

Stock Details

Ticker Symbol FLRY3
Exchange Brazil Stock Exchange
Fiscal Year January - December
Reporting Currency BRL
ISIN Number BRFLRYACNOR5
SIC Code 2834

Key Executives

Name Position
Jeane Mike Tsutsui Chief Executive Officer and President of Executive Board
Jose Antonio de Almeida Filippo Chief Financial Officer, Investor Relations Officer and Member of Executive Board
Claudio Almeida Prado Executive Director of New Links and Member of Executive Board
Edgar Gil Rizzatti Medical, Technical and Process Executive Director and Member of Executive Board
Roberto Santoro Meirelles L2L and Operations Support Officer and Member of Executive Board
Angelica Dente de Menezes Secretary